BriaCell Therapeutics Corp.

NASDAQ (USD): BriaCell Therapeutics Corp. (BCTX)

Last Price

0.561

Today's Change

-0.024 (4.10%)

Day's Change

0.561 - 0.624

Trading Volume

902,313

Overview

Market Cap

24 Million

Shares Outstanding

44 Million

Avg Volume

2,574,949

Avg Price (50 Days)

0.81

Avg Price (200 Days)

1.29

PE Ratio

-0.63

EPS

-0.89

Earnings Announcement

17-Mar-2025

Previous Close

0.59

Open

0.62

Day's Range

0.561 - 0.6242

Year Range

0.46 - 5.97

Trading Volume

901,927

Price Change Highlight

1 Day Change

-4.12%

5 Day Change

-13.69%

1 Month Change

-28.90%

3 Month Change

-13.56%

6 Month Change

-53.25%

Ytd Change

-89.49%

1 Year Change

-86.01%

3 Year Change

-93.76%

5 Year Change

-95.33%

10 Year Change

-98.66%

Max Change

-99.64%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment